David R. Lancia

Molecular basis of USP7 inhibition by selective small-molecule inhibitors

A.P. Turnbull, Stephanos Ioannidis, Wojciech Krajewski et al. · Nature · 2017 · 448 citations

Drug Target, Usp7 Inhibition, Medicine +4

Chemically Induced Degradation of the Oncogenic Transcription Factor BCL6

Nina Kerres, Steffen Steurer, Stefanie Schlager et al. · Cell Reports · 2017 · 199 citations · Full text

Identification of Hot Spots within Druggable Binding Regions by Computational Solvent Mapping of Proteins

Melissa Landon, David R. Lancia, Jessamin Yu et al. · Journal of Medicinal Chemistry · 2007 · 128 citations

Drug Target, Protein Assembly, Molecular Biology +18

Quantitative Comparison of Enrichment from DNA-Encoded Chemical Library Selections

John C. Faver, Kevin Riehle, David R. Lancia et al. · ACS Combinatorial Science · 2019 · 90 citations · Full text

Engineering, Hit Identification, Dna Analysis +25

Discovery of novel N-hydroxy-2-arylisoindoline-4-carboxamides as potent and selective inhibitors of HDAC11

Matthew W. Martin, Jennifer Y. Lee, David R. Lancia et al. · Bioorganic & Medicinal Chemistry Letters · 2018 · 64 citations · Full text

Medicinal Chemistry, Biochemistry, Novel N-hydroxy-2-arylisoindoline-4-carboxamides +9